Abstract
This chapter provides the reader with an introduction to the management of emergent vascular access for patients experiencing cardiac arrest. Special attention is paid to difficulties arising as a result of the emergent nature of cardiac arrest resuscitation, including difficulties in generating adequate organ and limb perfusion. Available vascular access techniques are discussed, including the evidence for preferring one vascular access device over another. A potential algorithm for managing emergent vascular access for this clinical condition is described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Panchal AR, Bartos JA, Cabanas JG, et al. Part 3: adult basic and advanced life support. 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2020;142(Suppl2):S366–468.
Jacobs IG, Finn JC, Jelinek GA, et al. Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial. Resuscitation. 2011;82:1138–43.
Perkins GD, Ji C, Deakin CD, et al. A randomized trial of epinephrine in out-of-hospital cardiac arrest. N Engl J Med. 2018;379:711–21.
Halperin HR, Tsitlik JE, Gelfand M, et al. A preliminary study of cardiopulmonary resuscitation by circumferential compression of the chest with use of a pneumatic vest. N Engl J Med. 1993;329:762–8.
Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA. 2002;288:3035–8.
Hoek TLV, Becker LB, Shao Z, et al. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 1998;273:18092–8.
Hoek TLV, Becker LB, Shao ZH, et al. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res. 2000;86:541–8.
Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out-of-hospital ventricular fibrillation, 1980–2000. JAMA. 2002;288:3008–13.
Nolan JP, Perkins GD. Is there a role for adrenaline during cardiopulmonary resuscitation? Curr Opin Crit Care. 2013;19:169–74.
Kudenchuk PJ, Sandroni C, Drinhaus HR, et al. Breakthrough in cardiac arrest: reports from the 4th Paris international conference. Ann Intensive Care. 2015;5:22.
Cummins RO, Ornato JP, Thies WH, et al. Improving survival from sudden cardiac arrest: the “chain of survival” concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation. 1991 May;83(5):1832–47.
Link MS, Berkow LC, Kudenchuk PJ, et al. Part 7: Adult Advanced Cardiovascular Life Support. 2015 American heart Association Guidelines Update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(suppl 2):S444–64.
Panchal AR, Berg KM, Hirsch KG, et al. 2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: use of advanced airways, vasopressors, and extracorporeal cardiopulmonary resuscitation during cardiac arrest: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2019;140:e881–94.
Hagihara A, Hasegawa M, Abe T, et al. Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA. 2012;307(11):1161–8.
Bendixen HH, Laver MB, Flacke WE. Influence of respiratory acidosis on circulatory effect of epinephrine in dogs. Circ Research. 1963;13(1):64.
Angelos MG, Butke RL, Panchal AR, et al. Cardiovascular reponse to epinephrine varies with increasing duration of cardiac arrest. Resuscitation. 2008;77:101–10.
Van Walraven C, Stiell IG, Wells GA, et al. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC Study Group. Ann Emerg Med. 1998;32(5):544–53.
Macht DI. Studies on intraosseous injection of epinephrine. Am J Physiol. 1943:269–72.
Spivey WH, Crespo SG, Fuhs LR, Schoffstall JM. Plasma catecholamine levels after intraosseous epinephrine administration in a cardiac arrest model. Ann Emerg Med. 1992;21(2):127–31.
Zuercher M, Kern KB, Indik JH, et al. Epinephrine improves 24-hour survival in a swine model of prolonged ventricular fibrillation demonstrating that early intraosseous is superior to delayed intravenous administration. Anesth Analg. 2011;112:884–90.
Burgert J, Gegel B, Loughren M, et al. Comparison of tibial intraosseous, sternal intraosseous, and intravenous routes of administration on pharmacokinetics of epinephrine during cardiac arrest: a pilot study. AANA J. 2012;80(4):S6–S10.
Burgert J, Gegel BT, Johnson D. The pharmacokinetics of intravenous, tibial intraosseous and sternal intraosseous epinephrine during cardiopulmonary resuscitation in a swine model of cardiac arrest. Minerva Med. 2014;105(2 Suppl 1):35.
Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346(12):884–990.
Daya MR, Leroux BG, Dorian P, et al. Survival after intravenous versus intraosseous amiodarone, lidocaine, or placebo in out-of-hospital shock-refractory cardiac arrest. Circulation. 2020;141(3):188–98.
Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341(12):871–8.
Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation. 1988;77:392–7.
Manz M, Pfeiffer D, Jung W, Lueritz B. Intravenous treatment with magnesium in recurrent persistent ventricular tachycardia. N Trends Arrhythmias. 1991;7:437–42.
Bar-Joseph G, Abramson NS, Kelsey SF, et al. Brain Resuscitation Clinical Trial III (BRCT III) Study Group: improved resuscitation outcome in emergency medical systems with increased usage of sodium bicarbonate during cardiopulmonary resuscitation. Acta Anaesthesiol Scand. 2005;49(1):6–15.
Thrower WB, Darby TD, Aldinger EE. Studies of the relationship between sympatho-adrenal function, acid-base derangements and ventricular contractile force. Surg Forum. 1960;10:535.
Von Hoff DD, Kuhn JG, Burris HA III, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Am J Emerg Med. 2008;26(1):31–8.
Berg RA. Emergency infusion of catecholamines into bone marrow. Am J Dis Child. 1984;138(9):810–1.
McNamara RM, Spivey WH, Unger HD, Malone DR. Emergency applications of intraosseous infusion. J Emerg Med. 1987;5:97–101.
Spivey WH. Intraosseous infusions. J Pediatr. 1987;111:639–43.
Brunette DD, Fischer R. Intravenous access in pediatric cardiac arrest. Am J Emerg Med. 1998;6:577–9.
Glaeser PW, Hellmich TR, Szewczuga D, Losek JD, Smith DS. Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med. 1993;22:1119–24.
Guy J, Haley K, Zuspan SJ. Use of intraosseous infusion in the pediatric trauma patient. J Ped Surg. 1993;28(2):158–61.
Davidoff J, Fowler R, Gordon D, et al. Clinical evaluation of a novel intraosseous device for adults: prospective, 250–patient, multi-center trial. JEMS. 2005;30(10):s20–3.
Fiorito BA, Mirza F, Doran TM, et al. Intraosseous access in the setting of pediatric critical care transport. Pediatr Crit Care Med. 2005;6(1):50–3.
Valdes M, Araujo P, de Andres C, et al. Intraosseous administration of thrombolysis in out-of-hospital massive pulmonary thromboembolism. Emerg Med J. 2010;27(8):641–4.
Gazin N, Auger H, Jabre P, et al. Efficacy and safety of the EZ-IO intraosseous device: out-of-hospital implementation of a management algorithm for difficult vascular access. Resuscitation. 2011;82:126–9.
Vorhees WD, Babbs CF, Tacker WA. Regional blood flow during CPR in dogs. Crit Care Med. 1980;8:134.
Del Guercio LRM, Coomarswamy RP, State D. Cardiac output and other hemodynamic variables during external cardiac massage in man. N Engl J Med. 1963;269:1398.
Oriol A, Smith HJ. Hemodynamic observations during cardiac massage. J Can Med Assoc. 1968;98:841.
Kuhn GJ, White BC, Swetnam RE, et al. Peripheral vs central circulation times during CPR: a pilot study. Ann Emerg Med. 1981;10(8):417–9.
Leidel BA, Kirchhoff C, Bogner V, et al. Comparison of intraosseous versus central venous vascular access in adults under resuscitation in the emergency department with inaccessible peripheral veins. Resuscitation. 2012;83(1):40–5.
Paxton JH, Knuth TE, Klausner HA. Proximal humerus intraosseous infusion: a preferred emergency venous access. J Trauma. 2009;67(3):606–11.
Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Ann Emerg Med. 2011;58(6):509–16.
Feinstein BA, Stubbs BA, Rea T, et al. Intraosseous compared to intravenous drug resuscitation in out-of-hospital cardiac arrest. Resuscitation. 2017;117:91–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Meram, S., Falcon, T., Paxton, J.H. (2021). Special Populations: Cardiac Arrest. In: Paxton, J.H. (eds) Emergent Vascular Access. Springer, Cham. https://doi.org/10.1007/978-3-030-77177-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-77177-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-77176-8
Online ISBN: 978-3-030-77177-5
eBook Packages: MedicineMedicine (R0)